SD Biosensor, Inc (KRX:137310)

SD Biosensor Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	273,647	177,424	482,383	1,872,944	881,593	243,216
Short-Term Investments	473,586	280,315	75,334	48,238	323,595	100,683
Trading Asset Securities	13,877	10,011	-	148,789	690,310	95,014
Cash & Short-Term Investments	761,110	467,750	557,717	2,069,971	1,895,499	438,913
Cash Growth	71.75%	-16.13%	-73.06%	9.21%	331.86%	1017.53%
Accounts Receivable	137,906	136,590	140,526	108,264	207,601	380,535
Other Receivables	-	25,216	5,483	879.37	8,342	25,375
Receivables	137,906	163,079	147,156	109,917	216,427	405,987
Inventory	239,680	232,170	195,621	254,663	353,248	366,364
Prepaid Expenses	-	48,139	41,430	37,918	43,946	42,383
Other Current Assets	75,434	27,257	23,045	44,796	97,668	35,614
Total Current Assets	1,214,129	938,393	964,970	2,517,266	2,606,788	1,289,261
Property, Plant & Equipment	479,912	485,610	551,500	468,635	207,128	115,250
Long-Term Investments	299,016	239,993	212,176	62,563	56,133	8,151
Goodwill	1,267,551	1,371,292	1,211,637	44,004	35,320	4,867
Other Intangible Assets	637,285	723,116	728,677	23,366	2,724	650.57
Long-Term Accounts Receivable	-	216.56	742.81	316.96	-0	-
Long-Term Deferred Tax Assets	16,256	16,912	14,683	38,175	18,030	21,559
Other Long-Term Assets	7,088	111,175	102,303	105,842	106,999	21,039
Total Assets	3,921,238	3,888,464	3,788,831	3,261,922	3,033,933	1,461,651
Accounts Payable	41,583	49,274	31,875	45,251	134,631	429,329
Accrued Expenses	-	12,702	12,373	10,609	6,468	24,169
Short-Term Debt	7,650	4,345	4,973	6,358	170,700	1,694
Current Portion of Long-Term Debt	21.28	44.55	128,940	-	-	-
Current Portion of Leases	6,909	7,049	7,030	12,607	6,590	4,267
Current Income Taxes Payable	3,896	5,212	6,336	190,121	351,979	112,251
Other Current Liabilities	101,340	97,937	129,231	32,034	109,502	117,693
Total Current Liabilities	161,400	176,564	320,758	296,980	779,869	689,402
Long-Term Debt	571,084	586,300	461,831	147.43	274.92	-
Long-Term Leases	11,901	13,124	5,702	11,581	18,103	14,536
Pension & Post-Retirement Benefits	4,386	4,007	3,480	766.66	311.81	153.35
Long-Term Deferred Tax Liabilities	107,021	127,155	147,194	4.64	-	-
Other Long-Term Liabilities	34,709	49,035	18,319	5,661	3,165	7.92
Total Liabilities	890,500	956,184	957,285	315,141	801,724	704,100
Common Stock	60,875	62,239	62,239	52,192	51,636	46,659
Additional Paid-In Capital	713,217	913,100	913,099	616,185	579,565	77,070
Retained Earnings	2,219,554	1,786,982	1,885,440	2,382,819	1,668,702	625,083
Treasury Stock	-128,279	-118,117	-99,691	-99,691	-99,644	-
Comprehensive Income & Other	157,341	279,129	62,573	-7,202	19,092	-791.43
Total Common Equity	3,022,707	2,923,334	2,823,660	2,944,301	2,219,351	748,021
Minority Interest	8,030	8,947	7,887	2,480	12,858	9,530
Shareholders' Equity	3,030,737	2,932,281	2,831,546	2,946,781	2,232,209	757,551
Total Liabilities & Equity	3,921,238	3,888,464	3,788,831	3,261,922	3,033,933	1,461,651
Total Debt	597,566	610,862	608,476	30,694	195,668	20,498
Net Cash (Debt)	163,545	-143,112	-50,759	2,039,277	1,699,830	418,416
Net Cash Growth	-	-	-	19.97%	306.25%	1594.22%
Net Cash Per Share	1352.98	-1171.11	-457.86	20131.28	17430.38	4474.28
Filing Date Shares Outstanding	119.62	120.62	122.35	102.25	101.14	93.32
Total Common Shares Outstanding	119.62	120.62	122.35	102.25	101.14	93.32
Working Capital	1,052,730	761,830	644,212	2,220,286	1,826,919	599,859
Book Value Per Share	25269.41	24236.47	23079.02	28794.15	21943.04	8015.85
Tangible Book Value	1,117,872	828,926	883,346	2,876,932	2,181,307	742,503
Tangible Book Value Per Share	9345.25	6872.37	7219.97	28135.30	21566.89	7956.72
Land	85,009	87,538	88,988	83,771	40,358	8,759
Buildings	120,350	92,958	132,470	58,144	36,449	29,790
Machinery	170,348	252,710	294,004	212,481	95,420	52,067
Construction In Progress	80,410	160,947	114,144	139,232	38,237	29,318

Source: S&P Global Market Intelligence. Standard template. Financial Sources.